Anand Patel
LightNews LightNews
banner
anand-88-patel.bsky.social
Anand Patel
@anand-88-patel.bsky.social
510 followers 480 following 280 posts
Leukemia & myeloid malignancy doctor. posts=mine. Repost≠endorsement. He/him. https://scholar.google.com/citations?user=kNhjy-MAAAAJ&hl=en
Posts Replies Media Videos
anand-88-patel.bsky.social
Day 14 - real-world outcomes of intensive chemo in CBF-AML

pubmed.ncbi.nlm.nih.gov/39157611/
October 12, 2025 at 11:35 AM
anand-88-patel.bsky.social
Day 13 - Real-world outcomes of CALGB10403 in AYAs with ALL

ashpublications.org/bloodneoplas...
October 11, 2025 at 12:49 PM
anand-88-patel.bsky.social
Day 12 - drivers of early mortality in APL

pubmed.ncbi.nlm.nih.gov/34269798/
October 10, 2025 at 11:15 AM
anand-88-patel.bsky.social
Day 11 - AML-based risk stratification in MPN-AP/BP treated with lower-intensity therapy

pubmed.ncbi.nlm.nih.gov/39969200/
October 9, 2025 at 5:36 PM
anand-88-patel.bsky.social
Day 10 - outcomes of older adults with TP53m myeloid malignancy

pubmed.ncbi.nlm.nih.gov/41057316/
October 8, 2025 at 10:57 AM
anand-88-patel.bsky.social
Day 9 - MRD in NPM1m AML treated with lower-intensity venetoclax-based therapy

pubmed.ncbi.nlm.nih.gov/37647641/
October 7, 2025 at 4:52 PM
anand-88-patel.bsky.social
Day 8 - asciminib + dasatinib for Ph+ ALL

pubmed.ncbi.nlm.nih.gov/39374521/
October 7, 2025 at 2:19 AM
anand-88-patel.bsky.social
Day 7 - outcomes in TP53m AML with HMA vs HMA+VEN

www.nature.com/articles/s41...
October 5, 2025 at 8:22 PM
anand-88-patel.bsky.social
Day 6 - ldac-clad-ven in patients already treated with HMA plus Ven

haematologica.org/article/view...
October 4, 2025 at 6:01 PM
anand-88-patel.bsky.social
Day 5 - aza + ven + revumenib for newly dx NPM1m or KMT2Ar AML

ascopubs.org/doi/10.1200/...
October 3, 2025 at 1:56 PM